LC
FLGT icon

Lindbrook Capital’s Fulgent Genetics FLGT Stock Holding History

Lindbrook Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.72K Sell
102
-31
-23% -$528 ﹤0.01% 2322
2024
Q4 		$2.46K Sell
133
-139
-51% -$2.71K ﹤0.01% 2247
2024
Q3 		$5.91K Sell
272
-75
-22% -$1.68K ﹤0.01% 1944
2024
Q2 		$6.81K Buy
347
+234
+207% +$4.88K ﹤0.01% 1843
2024
Q1 		$2.45K Buy
113
+60
+113% +$1.49K ﹤0.01% 2168
2023
Q4 		$1.53K Buy
+53
New +$1.42K ﹤0.01% 2358
2023
Q3 		– Sell
-8
Closed -$296 – 2731
2023
Q2 		$296 Sell
8
-29
-78% -$1.01K ﹤0.01% 2617
2023
Q1 		$1.16K Sell
37
-218
-85% -$7.02K ﹤0.01% 2426
2022
Q4 		$7.59K Sell
255
-160
-39% -$5.72K ﹤0.01% 1572
2022
Q3 		$16K Buy
415
+134
+48% +$6.72K ﹤0.01% 1097
2022
Q2 		$15K Buy
281
+31
+12% +$1.7K ﹤0.01% 1091
2022
Q1 		$16K Sell
250
-70
-22% -$4.61K ﹤0.01% 1099
2021
Q4 		$32K Sell
320
-30
-9% -$2.64K ﹤0.01% 864
2021
Q3 		$31K Buy
350
+50
+17% +$4.54K 0.01% 591
2021
Q2 		$28K Hold
300
– – 0.01% 661
2021
Q1 		$29K Sell
300
-50
-14% -$5.16K 0.01% 610
2020
Q4 		$18K Buy
350
+50
+17% +$2.09K ﹤0.01% 719
2020
Q3 		$12K Buy
+300
New +$9.39K ﹤0.01% 772

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Lindbrook Capital's FLGT Position: Q1 2025 in Review

Lindbrook Capital reduced its Fulgent Genetics (FLGT) stake by 23% in Q1 2025, selling an estimated $528 and leaving 102 shares worth $1.72K. The position accounts for ﹤0.01% of the portfolio, ranked #2322.

Lindbrook Capital first reported a position in FLGT in Q3 2020 and has held it in 18 quarters since. The position peaked at $32K in Q4 2021. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Lindbrook Capital held 102 shares of Fulgent Genetics worth $1.72K as of Q1 2025.
  • Lindbrook Capital sold 31 Fulgent Genetics shares in Q1 2025, an estimated $528.
  • Fulgent Genetics made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2322 holding.
  • Lindbrook Capital first reported a position in Fulgent Genetics in Q3 2020 and has held it in 18 quarters since.
  • Lindbrook Capital's Fulgent Genetics position peaked at $32K in Q4 2021.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.